Refine by
Patient Care Articles & Analysis: Older
737 news found
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that Tennessee Oncology, one of the United States’ largest community-based cancer care specialists that treats nearly half of Tennessee’s cancer patients across 35 clinics, has expanded its relationship with SOPHiA ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of Genomenon’s Mastermind® Genomic ...
The medical device industry is undergoing a transformative period marked by groundbreaking innovations and advanced materials. As healthcare continues to evolve, the need for devices that enhance patient outcomes while ensuring safety and reliability is more critical than ever. Among the various materials used in medical device design, polytetrafluoroethylene (PTFE tubing) has emerged as a ...
These are crucial tasks as the Centers for Disease Control and Prevention (CDC) reports that on any given day, about 1 in 31 patients receiving care in a hospital has at least one healthcare-associated infection (HAI). For nursing home residents, CDC shares that about 1 in 43 has at least one infection in association with their healthcare. HAIs are infections ...
A Centers for Disease Control and Prevention (CDC) report published on October 3, 2024, linked Burkholderia multivorans infections to ice machines in multiple healthcare facilities in the western United States. This post summarizes key findings, implications, and recommended practices for healthcare providers to ensure patient ...
These are crucial tasks as the Centers for Disease Control and Prevention (CDC) reports that on any given day, about 1 in 31 patients receiving care in a hospital has at least one healthcare-associated infection (HAI). For nursing home residents, CDC shares that about 1 in 43 has at least one infection in association with their healthcare. HAIs are infections ...
“With our expanded GMP production capabilities for PEG derivatives and associated lipids, we are poised to offer our clients dependable, scalable solutions that will propel their therapeutic developments and enhance patient outcomes.” For more information about Biopharma PEG’s extensive range of products and services, please visit our website at ...
“Infection prevention professionals and their prevention efforts and control practices are crucial tasks as the Centers for Disease Control and Prevention reports that on any given day, about 1 in 31 patients receiving care in a hospital has at least one healthcare-associated infection. ...
MedSource Labs understands the critical importance of ensuring clinician access to high-quality medical supplies, as it directly impacts patient care and outcomes. In the face of global challenges, such as supply chain disruptions due to a spike in geopolitical conflicts, the time it takes to move products by sea and air has vastly increased. ...
The research highlighted signatures identifying patients with non-squamous metastatic NSCLC who may derive higher OS benefit from the addition of tremelimumab to durvalumab plus chemotherapy in the first-line treatment setting. ...
Since launching the first generation of SOPHiA DDM™ in 2015, the Platform has been at the forefront of these innovations, accelerating the practice of data driven medicine globally as a leading platform in healthcare for using data to improve patient care. Data computed daily by the Platform has surged over the years with over 1.8 million genomic profiles ...
Cameron shares invaluable leadership and entrepreneurial insights, reflecting on the journey of founding and growing Synaptive globally, how he leverages artificial intelligence to enhance surgical outcomes and streamline medical procedures, and the importance of data collection in improving patient care and surgical precision. Click the link to listen to this ...
US-based MedSource Labs and Sydney’s Medilogic enter into an exclusive, strategic partnership in the peripheral safety IV market with the announcement of Logiflow Exactus and Logiflow Exactus Shield with Blood Control IV Catheters with active blood control check valve technology in ...
About CD Formulation Over the past years, CD Formulation has been strengthening its innovation in drug formulation and analytical testing, hoping to bring advancement for the pharmaceutical industry and also hoping to improve patient care on a global scale. Its latest product launch represents a significant step forward in cosmetic ingredient innovation. ...
Tempus, a leader in artificial intelligence and precision medicine, announced new testing solutions to help physicians identify patients with HER2 or FOLR1 expressing tumors, which may make such patients eligible for targeted therapies such as antibody–drug conjugates (ADCs). ...
ByTempus
Currently, ~30-40% of eligible NSCLC patients do not receive appropriate testing1. In September 2023, Tempus and AstraZeneca initiated a pilot program to leverage Next to identify this specific care gap at participating provider sites, using AI to scan unstructured clinical data to understand which patients may be eligible for testing based on ...
ByTempus
The research demonstrates a clinical sensitivity at a landmark of 61.1% and a robust surveillance performance with longitudinal sensitivity of 83.3% and specificity of 89.5% across stage II/III CRC patients. xM MRD results predict disease-free survival (DFS) nearly 5 times stronger compared to standard of care carcinoembryonic antigen (CEA) level (Adj. ...
ByTempus
“The CE Mark represents a major step forward in enhancing patient care and safety for endovascular therapies in the EU, a market with a higher prevalence of PE when compared to the United States,” said Laura Piccinini, AngioDynamics Senior Vice President/General Manager, Endovascular Therapies and International. “This designation allows us to ...
MedSource Labs Moves the Needle in the Peripheral Safety IV Market With the announcement of ClearSafe Comfort® and TrueSafe Comfort® Blood Control IV Catheters with groundbreaking active check valve ...
This integrated approach is vital as disruptions in supply relationships can severely affect patient care in the US. The COVID-19 pandemic and geopolitical tensions have highlighted the fragility and vulnerabilities of global supply chains, emphasizing the urgent need for increased resilience. ...